Free Webinar: Efficient Patient Identification in ALS Clinical Trials

In collaboration with Julius Clinical, TRICALS will present the webinar: “Efficient Patient…

Words Lucie van Leeuwen.Published November 3, 2020
Free Webinar: Efficient Patient Identification in ALS Clinical Trials

In collaboration with Julius Clinical, TRICALS will present the webinar:Efficient Patient Identification in ALS Clinical Trials; Leveraging the Concept of Fast and Slow Progressors”. The webinar will take place on November 10, 2020 at 18:00 CET.

We are pleased to announce that this webinar will be presented by: Prof. Dr. Leonard van den Berg (Professor of Neurology and Chair of TRICALS) and Dr. Ruben van Eijk (Assistant Professor and Medical Statistician) from our TRICALS Centre at UMC Utrecht, the Netherlands.

Topics that will be covered, include:

  • Prediction-based inclusion criteria
  • Defining the concept of fast vs slow progressors
  • Addressing disease heterogeneity and reduce variance
  • Regulatory perspective (EMA) on prediction-based patient selection

Don’t miss this opportunity and register now by clicking the link: https://bit.ly/3oAnz2L. The webinar will be recorded, so even if you can’t make it, make sure to sign up to receive the replay!


Share

Related news

Webinar recording "Efficient Patient Identification in ALS Clinical Trials" now available
Webinar recording "Efficient Patient Identification in ALS Clinical Trials" now available
Two weeks ago, we presented the free webinar: “Efficient Patient Identification in […]
The ALXN1210 trial is recruiting participants
The ALXN1210 trial is recruiting participants
This phase 3 trial, which is sponsored by Alexion Pharmaceuticals, aims to […]
The VALOR Study – A Clinical Trial for People Living with SOD1-ALS
The VALOR Study – A Clinical Trial for People Living with SOD1-ALS
Biogen is conducting a clinical trial to evaluate the safety and potential […]
Swimming the Catalan coast to raise funds for TRICALS
Swimming the Catalan coast to raise funds for TRICALS
To raise funds for TRICALS, Daniel Rossinés has taken on an epic […]